MNTKMontauk Renewables, Inc.

$1.50-35% 1Y

$1.50

$1.1252 weeks$2.95

Is the price fair?

Mixed

In its normal P/E range. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 neutral, 2 without data

Vs its own P/E rangemid-range for this companyderived

In its normal range: P/E 45.7 vs a 57.5 median over 17 quarters (−21% vs median).

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

Montauk Renewables, Inc. trades at 45.7× earnings against 29.6× for the median Specialty Chemicals name, more expensive than its own group.

45.7

Trailing P/E · Specialty Chemicals median 29.6 · 1.54× the median: the market pays up for this one

Details›

Price / bookas of 2026-Q1: 0.62
EV / EBIToperating margin 0.59%: the multiple describes the denominator: not meaningful
EV / salesas of 2026-Q1: 1.64
Basic Materials median P/E203 names: 21.2
Specialty Chemicals median P/E43 names: 29.6
Market capitalisation: $390M

What the market has paid for these earnings: 17 quarters of its own multiple × $0.06 of trailing earnings per share
Method	Per share
Its own P/E history, lower quartile	$2.51
Its own P/E history, median	$3.45
Its own P/E history, upper quartile	$4.55
52-week range	$1.12 – $2.95
Today	$1.50

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

Ranks #21 of 33 by RyuScore